REG3A and cancer: Moreover, overexpression of REG3A reversed the reduction in growth of LIM1215-shREG1CP xenografts in nu/nu mice treated with Dox (Fig. 3h), consistent with the notion that REG1CP functions through REG3A to sustain cancer cell proliferation in vivo.